Cite

HARVARD Citation

    Bandini, M. et al. (2021). Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer. Journal of the National Cancer Institute. pp. 48-53. [Online]. 
  
Back to record